These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6088803)

  • 41. Biochemical characterization of an aphthovirus type C3 strain Resende attenuated for cattle by serial passages in chicken embryos.
    Sagedahl A; Giraudo AT; De Mello PA; Bergmann IE; La Torre JL; Scodeller EA
    Virology; 1987 Apr; 157(2):366-74. PubMed ID: 3029977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification.
    Sevilla N; Domingo E
    J Virol; 1996 Oct; 70(10):6617-24. PubMed ID: 8794296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the nucleotide sequence at the 5' end of RNAs from nine aphthoviruses, including representatives of the Seven serotypes.
    Harris TJ
    J Virol; 1980 Dec; 36(3):659-64. PubMed ID: 6257918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homopolymer tract length dependent enrichments in functional regions of 27 eukaryotes and their novel dependence on the organism DNA (G+C)% composition.
    Zhou Y; Bizzaro JW; Marx KA
    BMC Genomics; 2004 Dec; 5():95. PubMed ID: 15598342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential of recombination for the production of foot-and-mouth disease virus vaccine strains.
    McCahon D; King AM; Slade WR; Skinner HH; Haresnape J
    Dev Biol Stand; 1980; 46():223-30. PubMed ID: 6244999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis.
    Carrillo C; Dopazo J; Moya A; Gonzalez M; Martínez MA; Saiz JC; Sobrino F
    Virus Res; 1990 Jan; 15(1):45-55. PubMed ID: 2156389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of RNase T1 one- and two-dimensional analyses to the rapid identification of foot-and-mouth disease viruses.
    La Torre JL; Underwood BO; Lebendiker M; Gorman BM; Brown F
    Infect Immun; 1982 Apr; 36(1):142-7. PubMed ID: 6281186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study of poly(C) and poly(I)-poly(C) complexes with model phospholipid membranes by infrared spectroscopy].
    Savchenko EV; Korobeĭnicheva IK; Budker VG
    Biofizika; 1985; 30(5):844-8. PubMed ID: 4052482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic relationships between southern African SAT-2 isolates of foot-and-mouth-disease virus.
    Vosloo W; Knowles NJ; Thomson GR
    Epidemiol Infect; 1992 Dec; 109(3):547-58. PubMed ID: 1334842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability of foot-and-mouth disease virus, its genome and proteins at 37 degrees C.
    Razdan R; Sen AK; Rao BV; Suryanarayana VV
    Acta Virol; 1996 Feb; 40(1):9-14. PubMed ID: 8886092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of mixed foot-and-mouth disease virus infections in Saudi Arabia: prolonged circulation of an exotic serotype.
    Woodbury EL; Samuel AR; Knowles NJ; Hafez SM; Kitching RP
    Epidemiol Infect; 1994 Feb; 112(1):201-11. PubMed ID: 8119359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic and functional characterization of mouse attenuated and virulent variants of foot-and-mouth disease virus type O1 Campos.
    Jensen MJ; Moore DM
    Virology; 1993 Apr; 193(2):604-13. PubMed ID: 8384748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of Theiler's murine encephalomyelitis virus RNA.
    Rozhon EJ; Lipton HL; Brown F
    J Gen Virol; 1982 Aug; 61 (Pt 2)():157-65. PubMed ID: 6288854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative biochemical and serological analysis of five isolates of a single serotype of foot-and-mouth disease virus.
    Robson KJ; Crowther JR; King AM; Brown F
    J Gen Virol; 1979 Dec; 45(3):579-90. PubMed ID: 94348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the size of the continuous poly(G) site necessary for the biological activity of the poly(G).poly(C) complex].
    Vil'ner LM; Platonova GA; Kogan EM; Sidorov NS; Timkovskiĭ AL
    Vopr Virusol; 1985; 30(3):337-40. PubMed ID: 2996241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro.
    de la Torre JC; Alarcón B; Martínez-Salas E; Carrasco L; Domingo E
    J Virol; 1987 Jan; 61(1):233-5. PubMed ID: 3023704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus.
    Clarke BE; Brown AL; Currey KM; Newton SE; Rowlands DJ; Carroll AR
    Nucleic Acids Res; 1987 Sep; 15(17):7067-79. PubMed ID: 2821491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection.
    Toja M; Escarmís C; Domingo E
    Virus Res; 1999 Nov; 64(2):161-71. PubMed ID: 10518712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a nucleotide deletion in parts of polypeptide 3A in two independent attenuated aphthovirus strains.
    Giraudo AT; Beck E; Strebel K; de Mello PA; La Torre JL; Scodeller EA; Bergmann IE
    Virology; 1990 Aug; 177(2):780-3. PubMed ID: 2164734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical map of polypeptides specified by foot-and-mouth disease virus.
    Grubman MJ; Robertson BH; Morgan DO; Moore DM; Dowbenko D
    J Virol; 1984 May; 50(2):579-86. PubMed ID: 6323757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.